Nasal Alzheimer’s Vaccine To Start Human Trials for the First Time
Brigham and Women's Hospital in Boston Massachusetts will soon begin Phase I trials of a nasal vaccine designed to prevent or slow the progression of Alzheimer's disease (AD), a press release said. This is the first occasion when a nasal vaccine is being attempted for the disease, which affects more than six million people in the U.S. [...]









